- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PDD regimen: doxorubicin hydrochloride iposome, bortizomib and dexamethasone
Total 320 results
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Recurrent Ovarian Low Grade Serous Adenocarcinoma | Borderline Ovarian Serous Tumor | Micropapillary Serous Carcinoma | Recurrent Primary Peritoneal Serous AdenocarcinomaUnited States, United Kingdom
-
Children's Cancer Group, ChinaXiangya Hospital of Central South University; Qilu Hospital of Shandong University and other collaboratorsRecruitingT-cell Lymphoblastic LymphomaChina
-
Stanford UniversityNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingS0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast CancerBreast CancerUnited States, Puerto Rico, Canada
-
National Cancer Institute (NCI)RecruitingLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
The First Affiliated Hospital of Soochow UniversityNot yet recruiting
-
European Organisation for Research and Treatment...Terminated
-
Washington University School of MedicineCompleted
-
Shanghai Pudong HospitalCSPC Ouyi Pharmaceutical Co., Ltd.Recruiting
-
Southwest Oncology GroupNational Cancer Institute (NCI)WithdrawnMultiple Myeloma | Plasma Cell MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Grupo Oncologico Cooperativo del SurSuspended
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube... and other conditionsUnited States
-
M.D. Anderson Cancer CenterCompletedInvasive Breast Carcinoma | Triple-Negative Breast CarcinomaUnited States
-
National Cancer Institute (NCI)AstraZeneca; NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian... and other conditionsUnited States, Canada, Korea, Republic of, Japan
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
French Innovative Leukemia OrganisationMundipharma Pte Ltd.; Janssen, LPCompleted
-
Advenchen Laboratories, LLCActive, not recruitingFallopian Tube Carcinoma | Cervical Carcinoma | Endometrial Carcinoma | Ovarian Carcinoma | Primary Peritoneal CarcinomaKorea, Republic of, Spain, United States, United Kingdom, China, Italy
-
University Hospital Plymouth NHS TrustCompleted
-
Fondazione Italiana Linfomi - ETSRecruiting
-
Federal Research Institute of Pediatric Hematology...RecruitingBurkitt Lymphoma | Diffuse Large B-cell Lymphoma | Primary CNS Lymphoma | Primary Mediastinal Lymphoma | Non-hodgkin Lymphoma,B CellRussian Federation
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI)TerminatedColorectal Cancer | Metastatic CancerUnited States
-
European Organisation for Research and Treatment...CompletedLymphoma | Small Intestine CancerFrance, Belgium, Egypt, Netherlands, Croatia
-
Stanford UniversityNational Cancer Institute (NCI)Completed
-
Roswell Park Cancer InstituteCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
OncotherapeuticsCelgene CorporationUnknownMultiple MyelomaUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingBreast Cancer | Hormone-receptor Positive Breast CancerChina
-
National Cancer Institute (NCI)TerminatedUnspecified Childhood Solid Tumor, Protocol Specific | Peripheral T-cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Childhood Chronic Myelogenous Leukemia | Cutaneous B-cell Non-Hodgkin Lymphoma | Hepatosplenic T-cell Lymphoma | Intraocular Lymphoma | Recurrent Childhood Acute Lymphoblastic... and other conditionsUnited States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI)Withdrawn
-
University Hospital BirminghamCompletedBreast CancerUnited Kingdom
-
Tanja Andrea GruberRecruitingAcute Lymphoblastic Leukemia, Pediatric | Refractory Acute Lymphoblastic Leukemia | Relapsed Acute Lymphoblastic LeukemiaUnited States
-
National Cancer Institute (NCI)Completed
-
Margarida Magalhaes-SilvermanNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Primary Systemic Amyloidosis | Light Chain Deposition Disease | Extramedullary Plasmacytoma | Isolated Plasmacytoma of BoneUnited States
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Sun Yat-Sen Memorial Hospital...Active, not recruitingBreast Cancer | Neoadjuvant ChemotherapyChina
-
French Innovative Leukemia OrganisationTerminated
-
Medical Research CouncilCompletedLymphomaUnited Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene Corporation; Ortho Biotech Clinical Affairs, L.L.C.CompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Seromucinous Carcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Fallopian Tube Mucinous Adenocarcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent... and other conditionsUnited States, Puerto Rico
-
Vanderbilt-Ingram Cancer CenterCompleted
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Ovarian High Grade Serous Adenocarcinoma | Fallopian... and other conditionsUnited States, Puerto Rico
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Southwest Oncology Group; Cancer and Leukemia...Completed
-
German High-Grade Non-Hodgkin's Lymphoma Study...CompletedLymphomaGermany, Switzerland
-
European Organisation for Research and Treatment...NCIC Clinical Trials Group; Stichting Hemato-Oncologie voor Volwassenen Nederland and other collaboratorsCompletedLymphomaFrance, Netherlands, United Kingdom, Australia, Canada, Norway, Poland, Belgium, Italy, New Zealand, Denmark, Egypt, Hungary, Portugal, Slovakia, Slovenia, South Africa, Sweden
-
Chunyan Sun, MDRecruiting
-
National Cancer Institute (NCI)WithdrawnRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma
-
Cancer Trials IrelandCompleted
-
Roswell Park Cancer InstituteEisai Inc.CompletedRecurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube CancerUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed